Journal: Microorganisms
Article Title: Lacticaseibacillus casei IB1 Alleviates DSS-Induced Inflammatory Bowel Disease by Regulating the Microbiota and Restoring the Intestinal Epithelial Barrier
doi: 10.3390/microorganisms12071379
Figure Lengend Snippet: L. casei IB1 upregulated tight junction proteins to improve colonic barrier dysfunction in DSS-induced colitis mice. ( A – C ) Statistical analysis of Occludin, Claudin1, and Claudin2 levels in the colon. The data are shown as the means ± SEMs. # p < 0.05, ## p < 0.01, compared to the CON group. * p < 0.05, ** p < 0.01, compared to the DSS group.
Article Snippet: After that, the PVDF membranes were incubated with the primary antibodies overnight at 4 °C: NF-κBP65 (8242S, CST, 1:1000), NF-κBP-p65 (3033S, CST, 1:1000), P38 (8690S, CST, 1:1000), P-p38 (4511S, CST, 1:1000), ERK1/2 (4695S, CST, 1:1000), P-ERK1/2 (4370S, CST, 1:1000), JNK (67096S, CST, 1:1000), P-JNK (4668S, CST, 1:1000), Occludin (27260, Proteintech, Rosemont, IL, USA, 1:1000), Claudin1 (37–4900, Invitrogen, Waltham, MA, USA), Claudin2 (AF0128, Affbiotech, Cincinnati, OH, USA, 1:1000), and β-Actin (HC201, TransGen Biotech, Beijing, China, 1:1000).
Techniques: